$0.64
7.21% today
Nasdaq, Apr 04, 08:21 pm CET
ISIN
US00430H1023
Symbol
AXDX
Sector
Industry

Accelerate Diagnostics, Inc. Stock price

$0.70
-0.35 33.17% 1M
-1.13 61.81% 6M
-0.51 42.08% YTD
-0.21 23.24% 1Y
-13.21 95.00% 3Y
-74.21 99.07% 5Y
-226.31 99.69% 10Y
Nasdaq, Closing price Thu, Apr 03 2025
-0.01 0.71%
ISIN
US00430H1023
Symbol
AXDX
Sector
Industry

Key metrics

Market capitalization $17.52m
Enterprise Value $67.80m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 5.79
P/S ratio (TTM) P/S ratio 1.50
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth -2.99%
Revenue (TTM) Revenue $11.70m
EBIT (operating result TTM) EBIT $-35.31m
Free Cash Flow (TTM) Free Cash Flow $-24.70m
Cash position $16.30m
EPS (TTM) EPS $-2.21
P/S forward 1.42
EV/Sales forward 5.51
Short interest 2.52%
Show more

Is Accelerate Diagnostics, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Accelerate Diagnostics, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a Accelerate Diagnostics, Inc. forecast:

1x Buy
50%
1x Hold
50%

Analyst Opinions

2 Analysts have issued a Accelerate Diagnostics, Inc. forecast:

Buy
50%
Hold
50%

Financial data from Accelerate Diagnostics, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
12 12
3% 3%
100%
- Direct Costs 8.99 8.99
8% 8%
77%
2.70 2.70
28% 28%
23%
- Selling and Administrative Expenses 18 18
39% 39%
153%
- Research and Development Expense 17 17
34% 34%
143%
-32 -32
37% 37%
-273%
- Depreciation and Amortization 3.42 3.42
5% 5%
29%
EBIT (Operating Income) EBIT -35 -35
35% 35%
-302%
Net Profit -50 -50
19% 19%
-428%

In millions USD.

Don't miss a Thing! We will send you all news about Accelerate Diagnostics, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Accelerate Diagnostics, Inc. Stock News

Neutral
PRNewsWire
14 days ago
TUCSON, Ariz. , March 21, 2025 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX), an innovator in rapid in vitro diagnostics for microbiology, today announced the submission of its Accelerate WAVE™ system and positive blood culture gram-negative test kit to the U.S. Food and Drug Administration (FDA) for 510(k) clearance.
Neutral
PRNewsWire
14 days ago
TUCSON, Ariz. , March 21, 2025 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today reports financial results for the fourth quarter and year ended December 31, 2024.
Neutral
PRNewsWire
3 months ago
TUCSON, Ariz. , Jan. 10, 2025 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) (Accelerate), an in vitro diagnostics company dedicated to providing services that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections, today announced certain preliminary, unaudited results for the quarter and year ended December 31, 2024.
More Accelerate Diagnostics, Inc. News

Company Profile

Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. Its products include Accelerate Pheno and Accelerate PhenoTest. The company was founded on May 26, 1982 and is headquartered in Tucson, AZ.

Head office United States
CEO Jack Phillips
Employees 107
Founded 1982
Website acceleratediagnostics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today